Advertisement
10/28/2021

Camber adds 4 products to co-pay card program

Camber’s Copay Card Program is adding deferasirox tablets, dimethyl fumarate capsules, droxidopa capsules and vigabatrin oral solution.
Sandra Levy
Senior Editor
Sandra Levy profile picture

Camber has added four generic products to its copay card program to help save patients a substantial amount of money each year.

The products are deferasirox tablets, dimethyl fumarate capsules, droxidopa capsules and vigabatrin oral solution.

“Camber’s Copay Card Program is designed to help patients by increasing access to affordable medicines and improving health outcomes” Kon Ostaficiuk, president of Camber said.

[Read more: Camber opens new headquarters in New Jersey]

Numerous studies have shown prescription copayments are a major incentive to drug adherence. In some cases, patients never fill prescriptions or ration medicine or doses to save money.

“Adding these prescriptions to a copay plan makes Camber’s products very attractive to patients and retailers alike. With many prescription drug insurance plans, the patient could have little-to-no copayment,” Ostaficiuk added.  “We hope this brings financial relief to more patients and encourages them follow their healthcare provider’s advice.”

Deferasirox is used to treat iron overload caused by blood transfusions in adults and children at least aged 2 years old.

[Read more: Camber debuts generic Revatio OS]

Dimethyl Fumarate is indicated for the treatment of relapsing forms of multiple sclerosis (MS).

Droxidopa is used to treat symptoms of low blood pressure when standing, caused by a certain medical condition, (neurogenic orthostatic hypotension)

Vigabatrin is used in combination with other medications to treat seizure disorders.

Advertisement
Advertisement